SEC Form 4 · accession 0001144204-15-021417
Accelerate Diagnostics, Inc · AXDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Pete Bantock
Officer — CHIEF COMMERCIAL OFFICER
Period of report
Apr 2, 2015
Accepted (ET)
Apr 6, 2015 · 6:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000727207
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $22.92 | Apr 2, 2015 | A | 3,547 | A | Apr 2, 2016 | Apr 2, 2025 | Common Stock | 3,547 | 215,053 | D |
| Employee Stock Option (right to buy)F1 | $9.83 | holding | — | — | — | Sep 4, 2018 | Sep 4, 2023 | Common Stock | 200,000 | 200,000 | D |
| Employee Stock Option (right to buy) | $14.92 | holding | — | — | — | Feb 26, 2015 | Feb 26, 2024 | Common Stock | 11,506 | 211,506 | D |
Explanation of responses
- F1The option is scheduled for 40% to vest on September 4, 2015, with the remainder vesting pro rata monthly through September 4, 2018.
- F2The option is scheduled to vest on April 2, 2016, the first anniversary of the date of grant.